000513.SZ
丽珠集团
SZSE · Healthcare · C 制造业 · CN
CNY 26.34
−9.98%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 11.7B | 12.0B | 11.8B | 12.4B | 12.6B |
| Cost of Revenue | 4.0B | 4.1B | 4.1B | 4.5B | 4.5B |
| Gross Profit | 7.7B | 7.9B | 7.7B | 8.0B | 8.2B |
| Operating Expenses | |||||
| R&D Expense | 891.3M | 937.9M | 1.0B | 1.3B | 1.4B |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 578.1M | 598.5M | 613.1M | 654.3M | 656.9M |
| Selling & Marketing Expense | 3.5B | 3.6B | 3.3B | 3.6B | 3.9B |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 5.0B | 5.1B | 4.9B | 5.5B | 5.8B |
| Cost and Expenses | 8.9B | 9.2B | 9.0B | 9.9B | 10.3B |
| Operating Income (EBIT) | 2.8B | 2.9B | 2.8B | 2.4B | 2.4B |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 2.8B | 2.9B | 2.8B | 2.4B | 2.3B |
| Income Tax Expense | 423.8M | 451.0M | 501.7M | 485.1M | 375.0M |
| Bottom Line | |||||
| Net Income | 2.0B | 2.0B | 2.1B | 2.0B | 1.9B |
| Earnings from Cont. Ops | 2.3B | 2.4B | 2.3B | 1.9B | 2.0B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 2.0B | 2.0B | 2.1B | 2.0B | 1.9B |
| Per Share | |||||
| Basic EPS | CN¥2.21 | CN¥2.27 | CN¥2.24 | CN¥2.10 | CN¥2.04 |
| Diluted EPS | CN¥2.21 | CN¥2.27 | CN¥2.24 | CN¥2.10 | CN¥2.04 |
| Revenue Per Share | CN¥13.19 | CN¥13.49 | CN¥12.84 | CN¥13.36 | CN¥13.49 |
| Shares | |||||
| Basic Shares Outstanding | 887.6M | 891.3M | 920.1M | 930.3M | 936.0M |
| Diluted Shares Outstanding | 887.6M | 891.3M | 920.1M | 930.3M | 936.0M |
| Profitability Metrics | |||||
| EBITDA | — | 3.5B | 3.5B | 3.3B | 3.0B |
| D&A | — | 603.8M | 608.0M | 866.4M | 663.9M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026